Cost-effectiveness of human papillomavirus (HPV) vaccination in Norway
HPV vaccination is highly efficacious against the development of high risk HPV 16/18 type related infections, the most common cause of cervical cancer. In Norway, the current screening strategy (since 1995) is to screen every 3 years, woman aged 25 to 69. How effective and cost-effective HPV vaccina...
| Otros Autores: | |
|---|---|
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Oslo, Norway :
Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH)
2007.
|
| Materias: | |
| Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009816732806719 |
